Trends impacting self-funding and stop loss – now and into 2024

A single treatment of breakthrough gene and cell therapies can cost millions of dollars. With that and other high-cost treatments in mind, self-funded employers are looking to their brokers to find the right stop loss insurance options to provide financial protection.

As a leading national stop loss company, HM Insurance Group (HM) tracks claim trends throughout the year. Join HM's president, Mark Lawrence and senior vice president of sales, Greg Wilden, as they discuss industry developments self-funded employers and the brokers who serve them need to keep on their radar.

Listen to this podcast to get answers to the following questions:

• What's contributing to the continued rise in the frequency and severity of claims?
• What do benefits professionals need to know about claim trends moving forward?
• What is anticipated to impact self-funded employers in 2024 and beyond?

Learn about these and other important trends and what you can do to meet self-funded challenges head on.